Evidence map›Paper›PMID 35548769›Full record

ArticleRSC advances2018

Novel oligopeptide nanoprobe for targeted cancer cell imaging.

Wen-Qiang Ding, Si-Yong Qin, Yin-Jia Cheng, Yi-Han Ma, Ai-Qing Zhang

Abstract read
In one paragraph

Article in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wen-Qiang DingCollege of Chemistry and Materials Science, South-Central University for Nationalities Wuhan 430074 P. R. China sy-qin@mail.scuec.edu.cn aizhang@scuec.edu.cn.
Si-Yong QinCollege of Chemistry and Materials Science, South-Central University for Nationalities Wuhan 430074 P. R. China sy-qin@mail.scuec.edu.cn aizhang@scuec.edu.cn.ORCID https://orcid.org/0000-0001-5034-3309
Yin-Jia ChengCollege of Chemistry and Materials Science, South-Central University for Nationalities Wuhan 430074 P. R. China sy-qin@mail.scuec.edu.cn aizhang@scuec.edu.cn.
Yi-Han MaCollege of Chemistry and Materials Science, South-Central University for Nationalities Wuhan 430074 P. R. China sy-qin@mail.scuec.edu.cn aizhang@scuec.edu.cn.
Ai-Qing ZhangCollege of Chemistry and Materials Science, South-Central University for Nationalities Wuhan 430074 P. R. China sy-qin@mail.scuec.edu.cn aizhang@scuec.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here we designed and constructed a tryptophan-phenylalanine-phenylalanine-tryptophan (WFFW) tetrapeptide, which generated photostable and tunable fluorescence emission signals from 340 nm to 500 nm. The WFFW tetrapeptide could self-assemble into a spherical nanostructure with enhanced fluorescence intensity. Driven by π-π stacking and hydrogen bond interaction, WFFW co-assembled with arginine-glycine-aspartic acid (RGD) modified WFFW to form a cancer-targeted fluorescent nanoprobe, which could selectively image the cancer cells.

Identifiers

PMID35548769
PMCPMC9085486

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.